Revelation Historical Cash Flow
| REVB Stock | USD 0.76 0.01 0.67% |
Analysis of Revelation Biosciences cash flow over time is an excellent tool to project Revelation Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Net Borrowings of 1.1 M or Total Cashflows From Investing Activities of 31.1 M as it is a great indicator of Revelation Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Revelation Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Revelation Biosciences is a good buy for the upcoming year.
Revelation |
About Revelation Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Revelation balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Revelation's non-liquid assets can be easily converted into cash.
Revelation Biosciences Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Revelation Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.At present, Revelation Biosciences' Change To Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Investments is expected to grow to about 19.5 K, whereas Capital Expenditures is forecasted to decline to 3.80.
Revelation Biosciences cash flow statement Correlations
Click cells to compare fundamentals
Revelation Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Revelation Biosciences cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 804K | 861K | 526K | 132.0K | 4.0 | 3.8 | |
| Net Income | (3.6K) | (1.6M) | (12.0M) | (10.8M) | (120.3K) | (114.2K) | |
| Investments | (294.9M) | (368.6M) | (132.0K) | 16.2K | 18.6K | 19.5K | |
| Change In Cash | 10.7M | (74.2M) | (3.2M) | 4.0M | 6.7M | 12.3M | |
| Net Borrowings | (8.2M) | (14.4M) | 15K | 750K | 675K | 1.1M | |
| Total Cashflows From Investing Activities | (251.6M) | (294.9M) | (132.0K) | 25.7M | 29.6M | 31.1M | |
| Other Cashflows From Financing Activities | 10K | (65.4M) | 7.4M | 11.5M | (5.0K) | (4.7K) | |
| Depreciation | 1.5M | 1.7M | 16.8K | 25.0K | 25.0K | 23.8K | |
| Total Cash From Operating Activities | 41.1M | (215.1K) | (11.1M) | (11.2M) | (7.3M) | (6.9M) | |
| Total Cash From Financing Activities | 338.2M | 74.3M | 8.0M | 15.2M | 14.0M | 13.3M | |
| Other Cashflows From Investing Activities | (1.0M) | 1.5M | (74.0M) | 25.7M | 23.2M | 24.3M | |
| Change To Netincome | 3.0M | 4.7M | 43.8K | (1.0M) | (914.9K) | (869.1K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revelation Biosciences is a strong investment it is important to analyze Revelation Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Revelation Biosciences' future performance. For an informed investment choice regarding Revelation Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (17.53) | Return On Assets (0.51) | Return On Equity (2.70) |
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.